# Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/par-23-026-ancillary-studies-to-ongoing-clinical-projects-r21-clinical/  
Official notice: https://www.grants.gov/search-results-detail/344598

> National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on December 8, 2024.

| Field | Value |
|---|---|
| Opportunity number | PAR-23-026 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | December 8, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.846 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

## Questions people ask

### Is PAR-23-026 still open?

No. It closed on December 8, 2024.

### Who can apply for Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)?

Closed December 8, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-23-026?

NIH RePORTER lists 2 projects funded under PAR-23-026 in fiscal 2024 to 2025, at 2 institutions. The most were at Utah State Higher Education System--University of Utah, University of Colorado Denver.

### Who has won Arthritis, Musculoskeletal and Skin Diseases Research grants before?

The largest recipients over five fiscal years were The Trustees of the University of Pennsylvania, Brigham & Womens Hospital Inc, The Regents of the University of California, San Francisco. The program made 2,897 awards worth $2.6 billion in that time.